SCHEMBL6878476

SCHEMBL6878476

CCOC(OCC)c1ccc(C=CC=C2SC(=S)N(CC(=O)O)C2=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 6/20 0.68
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
MAPT P10636 4/20 0.68
ALDH1A1 P00352 3/20 0.68
NPC1 O15118 3/20 0.68
HTT P42858 2/20 0.50
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
PTPN12 Q05209 1/20 0.49
PTPN22 Q9Y2R2 1/20 0.49
MMP3 P08254 1/20 0.48
PTPN1 P18031 1/20 0.48
MMP13 P45452 1/20 0.48
MAPK1 P28482 2/20 0.48
THRB P10828 1/20 0.48
RECQL P46063 1/20 0.48
RAB9A P51151 1/20 0.48
BLM P54132 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4863223 0.83 MAPT (0.80) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL7537933 0.83 MAPT (0.80) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL10492259 0.81 MAPT (1.00) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL1315178 0.81 MAPT (1.00) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL6887148 0.81 MAPT (0.73) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL6888015 0.81 AKR1B1 (0.69) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL6888013 0.81 AKR1B1 (0.69) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL6886616 0.81 KMT2A (0.80) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL6886621 0.81 KMT2A (0.80) AKR1B1MEN1KMT2AMAPTALDH1A1
SCHEMBL6885966 0.81 KMT2A (0.80) AKR1B1MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673816-B1 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders Esswein, Angelika (DE) 2004-01-06 US disclosed
EP-1117655-A1 RHODANINE CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS Esswein, Angelika (DE) 2001-07-25 EP disclosed
WO-2000018747-A1 RHODANINE CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed